Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

SHE/300453 stock hub

SHE/300453 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300453is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.5B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300453

In the news

Latest news · SHE/300453

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E19.6

P25 23.5P50 41.3P75 83.2

ROE19.8

P25 -0.9P50 4.1P75 8.8

ROIC24.6

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300453 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

235

Groups with data

Currency

CNY

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	2,157
Employees Change	230%
Employees Change Percent	11.94
Enterprise value	CNY 5.3B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	CNE100001ZJ1
Last refreshed	2026-05-10
Market cap	CNY 5.5B
Price	CNY 10.61
Price currency	CNY
Rev Per Employee	782,794.56x
Sector	Healthcare
Sic	3841
Symbol	she/300453
Website	https://www.sanxin-med.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.12%
EV Earnings	18.78x
EV/EBIT	15.06x
EV/EBITDA	10.99x
EV/FCF	28.65x
EV/Sales	3.11x
FCF yield	3.36%
P/B ratio	3.37x
P/E ratio	19.6x
P/S ratio	3.23x
PE Ratio10 Y	40.6x
PE Ratio3 Y	17.99x
PE Ratio5 Y	21.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	20.64%
EBITDA Margin	28.22%
FCF margin	10.85%
Gross margin	36.59%
Gross Profit	CNY 617.8M
Gross Profit Growth	14.46%
Gross Profit Growth Q	21.54%
Gross Profit Growth3 Y	13.25%
Gross Profit Growth5 Y	13.77%
Net Income	CNY 279.6M
Net Income Growth	22.88%
Net Income Growth Q	27.23%
Net Income Growth Quarters	5%
Net Income Growth Years	7%
Net Income Growth3 Y	15.39%
Net Income Growth5 Y	15.24%
Pretax Margin	20.43%
Profit Margin	16.56%
Profit Per Employee	CNY 129,610
Profitable Years	15
ROA	9.33
Roa5y	8.11
ROCE	18.52
ROE	19.81
Roe5y	18.62
ROIC	24.59
Roic5y	21.24

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.98%
Cagr1y	34.52%
Cagr3y	15.08%
Cagr5y	4.62%
Div CAGR3	37.51%
Div CAGR5	42.38%
EPS Growth	22.9
EPS Growth Q	28.41
EPS Growth Quarters	4
EPS Growth Years	7
EPS Growth3 Y	15.35
EPS Growth5 Y	15.63
FCF Growth	-1.68%
FCF Growth3 Y	15.84%
FCF Growth5 Y	4.64%
OCF Growth	1.38%
OCF Growth Q	-77.77%
OCF Growth10 Y	17.77%
OCF Growth3 Y	5.73%
OCF Growth5 Y	10.15%
Revenue Growth	10.37x
Revenue Growth Q	13.39x
Revenue Growth Quarters	11x
Revenue Growth Years	2x
Revenue Growth3 Y	9.46x
Revenue Growth5 Y	10.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.72
Assets	CNY 2.4B
Cash	CNY 518.6M
Current Assets	CNY 918.1M
Current Liabilities	CNY 562.2M
Debt	CNY 223M
Debt EBITDA	CNY 0.47
Debt Equity	CNY 0.14
Debt FCF	CNY 1.22
Equity	CNY 1.6B
Liabilities	CNY 825M
Long Term Assets	CNY 1.5B
Long Term Liabilities	CNY 262.8M
Net Cash	CNY 295.6M
Net Cash By Market Cap	CNY 5.42
Net Cash Growth	4.56%
Net Debt EBITDA	CNY -0.62
Net Debt Equity	CNY -0.18
Net Debt FCF	CNY -1.61
Tangible Book Value	CNY 1.3B
Tangible Book Value Per Share	CNY 2.54
WACC	5.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.63
Inventory Turnover	4.91
Net Working Capital	CNY -119.9M
Quick ratio	1.1
Working Capital	CNY 355.9M
Working Capital Turnover	CNY 5.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.02%
Dividend Growth	20%
Dividend Growth Years	3%
Dividend per share	CNY 0.3
Dividend Years	10
Dividend Yield	2.83%
Last Dividend	CNY 0.1
Payout Ratio	58.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	34.17%
1Y total return	34.49%
200-day SMA	9.44
3Y total return	52.4%
50-day SMA	9.79
50-day SMA vs 200-day SMA	50over200
5Y total return	25.32%
All Time High	16.38
All Time High Change	-35.21%
All Time High Date	2015-06-12
All Time Low	2.5
All Time Low Change	323.89%
All Time Low Date	2018-10-19
ATR	0.35
Beta	0.3
Beta1y	0.04
Beta2y	0.29
Ch YTD	21.67
High	10.65
High52	11.64
High52 Date	2025-08-19
High52ch	-8.85%
Low	10.27
Low52	7.7
Low52 Date	2025-06-19
Low52ch	37.79%
Ma50ch	8.42%
Price vs 200-day SMA	12.44%
RSI	63.89
RSI Monthly	66.58
RSI Weekly	61.22
Sharpe ratio	0.95x
Sortino ratio	1.83
Total Return	2.84%
Tr YTD	21.67
Tr1m	9.61%
Tr1w	3.61%
Tr3m	11.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 348.6M
Operating Income Growth	20.48
Operating Income Growth Q	34.02
Operating Income Growth3 Y	20.87
Operating Income Growth5 Y	16.66
Operating margin	20.64

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	318,692,027%
Net Borrowing	11,321,800
Shares Insiders	38.03%
Shares Institutions	4.58%
Shares Out	514,261,875
Shares Qo Q	-0.01%
Shares Yo Y	-0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 183.3M
Average Volume	15,286,845.75x
Bv Per Share	2.95
CAPEX	CNY -233.3M
Ch10y	16.56
Ch1m	9.61
Ch1w	3.61
Ch1y	29.87
Ch3m	11.8
Ch3y	41.85
Ch5y	13.05
Ch6m	6.85
Change	2.41%
Change From Open	2.22
Close	10.36
Days Gap	0.19
Depreciation Amortization	127,867,174
Dollar Volume	248,212,196.8
Earnings Date	2026-04-27
EBIT	CNY 348.6M
EBITDA	CNY 476.4M
EPS	CNY 0.54
F Score	7
FCF	CNY 183.3M
FCF EV Yield	3.49x
FCF Per Share	CNY 0.36
Financing CF	-169,300,148
Fiscal Year End	December
Founded	1,997
Goodwill	79,576,308
Graham Number	5.99533
Graham Upside	-43.49
Income Tax	CNY 38.6M
Investing CF	-236,946,277
Is Primary Listing	1
Last Earnings Date	2026-04-27
Last Report Date	2026-03-31
Last Split Date	2023-04-24
Last Split Type	Forward
Lynch Fair Value	CNY 8.25
Lynch Upside	-22.24
Ma150	9.46
Ma150ch	12.11%
Ma20	9.95
Ma20ch	6.63%
Net CF	10,236,985
Next Earnings Date	2026-08-07
Open	10.38
P FCF Ratio	29.78
P OCF Ratio	13.1
Payment Date	2025-09-10
Position In Range	89.47
Ppne	1,198,663,996
Price Date	2026-05-08
Price EBITDA	CNY 11.45
Ptbv Ratio	4.15
Relative Volume	1.54x
Revenue	1,688,487,862x
Tax By Revenue	2.29x
Tax Rate	11.19%
Tr6m	6.85%
Volume	23,394,175

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300453 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.8%

$0.30 annual per share

Payout ratio

+58.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+42.4%

3 consecutive years of growth

Total shareholder yield

+2.8%

Dividend yield + buyback yield combined

Performance

SHE/300453 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300453?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.6%

Share of float held by funds and institutions

Insider ownership

+38.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

SHE/300453 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.9

Neutral momentum band

Price vs 200-day MA

+12.4%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

0.95

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300453

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300453 stock rating?

she/300453 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300453 analysis?

The full report lives at /stocks/she/300453/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300453?

The latest report frames she/300453 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300453 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.